Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination
- PMID: 12834312
- DOI: 10.7326/0003-4819-139-1-200307010-00006
Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination
Abstract
Background: Persons with atopic dermatitis or eczema, regardless of disease severity or activity, may develop eczema vaccinatum if they or their close contacts receive the smallpox vaccine. According to current recommendations, a preexposure vaccination program should identify these persons and exclude them from participating.
Objective: To determine the prevalence of diagnosed atopic dermatitis and eczema in a defined population and assess the sensitivity of screening questions to identify patients who have received these diagnoses.
Design: Population-based prevalence survey and telephone interview.
Setting: 14 ZIP code regions in Wisconsin.
Patients: Persons given a diagnosis of atopic dermatitis or eczema in 2000 and 2001 were identified from a population-based cohort. Persons with a history of atopic dermatitis diagnosed since 1979 were eligible for the telephone survey.
Measurements: Prevalence of diagnosed atopic dermatitis or eczema; proportions of respondents able to recall a past diagnosis of atopic dermatitis, eczema, or recurrent rash.
Results: The prevalence of atopic dermatitis or eczema diagnosis in 2000 or 2001 was 0.8%. At least 2.4% of the cohort would be ineligible for smallpox vaccination because of active skin disease in themselves or household members. Among 94 adult respondents with atopic dermatitis, 55 (59%) correctly self-reported skin disease. Seventy-nine (60%) of 133 household contacts of adults with atopic dermatitis correctly reported the presence of skin disease in a household member. Parental recall of skin disease in children with atopic dermatitis was 70% (123 of 177).
Conclusions: Identifying dermatologic contraindications to smallpox vaccination by relying only on a self-reported history of rash illnesses is likely to miss a substantial proportion of individuals who should not receive smallpox vaccine in a preexposure vaccination campaign.
Comment in
-
Summaries for patients. Recall of skin diseases that disqualify people from preexposure smallpox vaccination.Ann Intern Med. 2003 Jul 1;139(1):I-32. doi: 10.7326/0003-4819-139-1-200307010-00001. Ann Intern Med. 2003. PMID: 12834330 No abstract available.
Similar articles
-
Eczema vaccinatum.Clin Infect Dis. 2012 Mar;54(6):832-40. doi: 10.1093/cid/cir952. Epub 2012 Jan 30. Clin Infect Dis. 2012. PMID: 22291103 Review.
-
Smallpox, vaccination and adverse reactions to smallpox vaccine.Curr Opin Allergy Clin Immunol. 2004 Aug;4(4):271-5. doi: 10.1097/01.all.0000136758.66442.28. Curr Opin Allergy Clin Immunol. 2004. PMID: 15238792 Review.
-
Summaries for patients. Recall of skin diseases that disqualify people from preexposure smallpox vaccination.Ann Intern Med. 2003 Jul 1;139(1):I-32. doi: 10.7326/0003-4819-139-1-200307010-00001. Ann Intern Med. 2003. PMID: 12834330 No abstract available.
-
Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).MMWR Recomm Rep. 2003 Apr 4;52(RR-7):1-16. MMWR Recomm Rep. 2003. PMID: 12710832
-
Smallpox vaccination and adverse reactions. Guidance for clinicians.MMWR Recomm Rep. 2003 Feb 21;52(RR-4):1-28. MMWR Recomm Rep. 2003. PMID: 12617510
Cited by
-
Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry.Dermatol Ther (Heidelb). 2023 Sep;13(9):2045-2061. doi: 10.1007/s13555-023-00980-6. Epub 2023 Jul 22. Dermatol Ther (Heidelb). 2023. PMID: 37481484 Free PMC article.
-
Frequency and influence of "not relevant" responses on the Dermatology Life Quality Index among adults with atopic dermatitis.Qual Life Res. 2021 Jun;30(6):1705-1713. doi: 10.1007/s11136-021-02770-z. Epub 2021 Feb 4. Qual Life Res. 2021. PMID: 33538979 Free PMC article.
-
Clinical onset of atopic eczema: Results from 2 nationally representative British birth cohorts followed through midlife.J Allergy Clin Immunol. 2019 Sep;144(3):710-719. doi: 10.1016/j.jaci.2019.05.040. Epub 2019 Jun 28. J Allergy Clin Immunol. 2019. PMID: 31260715 Free PMC article.
-
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.PLoS One. 2015 Oct 6;10(10):e0138348. doi: 10.1371/journal.pone.0138348. eCollection 2015. PLoS One. 2015. PMID: 26439129 Free PMC article. Clinical Trial.
-
Comorbidity in Atopic Dermatitis.Curr Dermatol Rep. 2012 Mar 1;1(1):29-38. doi: 10.1007/s13671-011-0003-5. Curr Dermatol Rep. 2012. PMID: 23745171 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous